Pediatric Dosing of Ganciclovir and Valganciclovir: How Model‐Based Simulations Can Prevent Underexposure and Potential Treatment Failure

por Jorga, Karin, Reigner, Bruno, Chavanne, Clarisse, Alvaro, Giuseppe, Frey, Nicolas
Publicado 2018

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia

por Gibiansky, Ekaterina, Gibiansky, Leonid, Chavanne, Clarisse, Frey, Nicolas, Jamois, Candice
Publicado 2021

Population Pharmacokinetic and Exposure–dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder Patients

por Cosson, Valérie, Schaedeli‐Stark, Franziska, Arab‐Alameddine, Mona, Chavanne, Clarisse, Guerini, Elena, Derks, Michael, Mallalieu, Navita L.
Publicado 2018

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyan...

por Jamois, Candice, Gibiansky, Leonid, Chavanne, Clarisse, Cheu, Melissa, Lehane, Patricia B., Pordeli, Pooneh, Melega, Simone, Gaudreault, Jacques
Publicado 2022

Quantitative Clinical Pharmacology Supports the Bridging From i.v. Dosing and Approval of s.c. Rituximab in B‐Cell Hematological Malignancies

por Jamois, Candice, Gibiansky, Ekaterina, Gibiansky, Leonid, Chavanne, Clarisse, Morcos, Peter N., McIntyre, Christine, Barrett, Martin, Lundberg, Linda, Zharkov, Artem, Boehnke, Axel, Frey, Nicolas
Publicado 2021